N-(3,3-dimethylindolin-6-yl)-2-[(1-oxidopyridin-1-ium-4-yl)methylamino]nicotinamide
Compound with spectra: 1 NMR
![N-(3,3-dimethylindolin-6-yl)-2-[(1-oxidopyridin-1-ium-4-yl)methylamino]nicotinamide](/api/compound/1THVPE26Rbl.png?ph=true&h=300&w=458 "N-(3,3-dimethylindolin-6-yl)-2-[(1-oxidopyridin-1-ium-4-yl)methylamino]nicotinamide")
| SpectraBase Compound ID | 1THVPE26Rbl |
|---|---|
| InChI | InChI=1S/C22H23N5O2/c1-22(2)14-25-19-12-16(5-6-18(19)22)26-21(28)17-4-3-9-23-20(17)24-13-15-7-10-27(29)11-8-15/h3-12,25H,13-14H2,1-2H3,(H,23,24)(H,26,28) |
| InChIKey | ASLJCBAIAYCPAX-UHFFFAOYSA-N |
| Mol Weight | 389.46 g/mol |
| Molecular Formula | C22H23N5O2 |
| Exact Mass | 389.185175 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|
AMG-706;MOTESANIB
2',3'-DICHLORO-2-(alpha,alpha,alpha-TRIFLUORO-m-TOLUIDINO)NICOTINANILIDE
3'-chloro-2'-methyl-2-(alpha,alpha,alpha-trifluoro-m-toluidino)nicotinanilide
2',5'-DICHLORO-2-(alpha,alpha,alpha-TRIFLUORO-m-TOLUIDINO)NICOTINANILIDE
2'-NITRO-2-(alpha,alpha,alpha-TRIFLUORO-m-TOLUIDINO)NICOTINANILIDE
5,6-Dihydro-9-chloro-11H-pyrido(3,2-C)(1)benzazepin-5-one
5,6-Dihydro-9-bromo-11H-pyrido(3,2-C)(1)benzazepin-5-one
2-(benzoylamino)-4,5-dimethoxy-N-(4-methylphenyl)benzamide
benzamide, 2-chloro-N-(9H-fluoren-2-yl)-
2'-[(cyclopropylmethyl)carbamoyl]-2-phenoxynicotinanilide
| Title | Journal or Book | Year |
|---|---|---|
| In Vitro Metabolism of the Novel, Highly Selective Oral Angiogenesis Inhibitor Motesanib Diphosphate in Preclinical Species and in Humans | Drug Metabolism and Disposition | 2009 |